Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 18,464 | 17,410 | 18,053 | 16,790 | 14,493 |
| Cost of Goods | 851 | 1,217 | 2,510 | 1,216 | 208 |
| Gross Profit | 17,613 | 16,193 | 15,543 | 15,574 | 14,285 |
| Operating Expenses | 54,028 | 45,451 | 49,666 | 55,768 | 50,642 |
| Operating Income | -35,564 | -29,041 | -33,613 | -39,978 | -36,149 |
| Interest Expense | 13,117 | 12,679 | 12,496 | 12,909 | 12,816 |
| Other Income | 4,802 | 5,410 | -334 | 11,027 | 2,154 |
| Pre-tax Income | -43,879 | -36,310 | -46,443 | -41,860 | -46,811 |
| Income Tax | 90 | 234 | 163 | 43,171 | -85 |
| Net Income Continuous | -43,969 | -36,544 | -46,606 | -85,031 | -46,726 |
| Net Income | $-43,969 | $-36,544 | $-46,606 | $-85,031 | $-46,726 |
| EPS Basic Total Ops | -0.42 | -0.38 | -0.56 | -1.04 | -0.57 |
| EPS Basic Continuous Ops | -0.42 | -0.38 | -0.56 | -1.03 | -0.57 |
| EPS Diluted Total Ops | -0.42 | -0.38 | -0.56 | -1.04 | -0.57 |
| EPS Diluted Continuous Ops | -0.42 | -0.38 | -0.56 | -1.03 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -0.42 | -0.38 | -0.56 | -1.03 | -0.58 |
| EBITDA(a) | $-34,762 | $-28,203 | $-32,770 | $-39,131 | $-35,264 |